Nkarta Inc

NEWS

Businessman holding a dart aiming at the target - business targeting, aiming, focus concept. Art collage.

Earnings

Q3 Biotech Earnings Recap: Nkarta, Intellia, Cassava and more

BioSpace takes a look at the headlines across a heavy earnings week for biotechs, checking in on Allogene, Rapport and more.

November 12, 2024

9 min read

Annalee Armstrong

Drug Development

Clinical Catch-Up: Genentech Announces Positive Data, Pfizer Develops New Vaccine

A roundup of last week’s top clinical trial updates and news.

April 29, 2022

10 min read

Mark Terry

Medical scientist studying blood sample under microscope, biochemical research

Drug Development

Nkarta’s NK Cell Therapies for Blood Cancer Tout Full Recoveries

Nkarta announced that two of its therapies have shown complete remission in patients with blood cancer. These results are the latest development in the treatment of difficult-to-treat blood cancers.

April 25, 2022

4 min read

Hannah Chudleigh

Bio NC

Clinical Catch-Up: October 4-8

Another busy week for clinical trial news. Here’s a look.

October 8, 2021

16 min read

Mark Terry

Business

Nkarta and CRISPR Therapeutics Join Forces to Develop Natural Killer Cell Cancer Treatments

Biopharmaceutical company CRISPR Therapeutics has entered into a strategic research, development and commercialization partnership with cancer-focused Nkarta.

May 7, 2021

3 min read

Brandon May

JOBS